Compare WLYB & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLYB | LMRI |
|---|---|---|
| Founded | 1807 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Books | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 2025 |
| Metric | WLYB | LMRI |
|---|---|---|
| Price | $32.30 | $14.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 2.2K | ★ 569.8K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $1,665,756,000.00 | $1,003,375,000.00 |
| Revenue This Year | $0.02 | $9.29 |
| Revenue Next Year | $2.32 | $5.01 |
| P/E Ratio | $15.52 | ★ N/A |
| Revenue Growth | N/A | ★ 1.38 |
| 52 Week Low | $29.79 | $9.97 |
| 52 Week High | $46.81 | $19.45 |
| Indicator | WLYB | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 50.13 |
| Support Level | $29.79 | $9.97 |
| Resistance Level | $32.65 | $14.03 |
| Average True Range (ATR) | 0.34 | 1.12 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 57.28 | 73.74 |
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.